WHO ICTRP trial
Memantine as an adjunctive therapy to ongoing clozapine treatment: a…
EUCTR2011-003466-33-NL · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2011-003466-33-NL |
|---|---|
| Public title | Memantine as an adjunctive therapy to ongoing clozapine treatment: a proof-of-concept study |
| Scientific title | Memantine Add-On Therapy to Clozapine - MAOTC |
| Primary sponsor | Mental Health Services North Holland North |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Netherlands |
| Conditions | Cognitive functioning, severity of psychopathology and treatment response (positive symptoms and negative symptoms of schizophrenia), depressive symptoms, social cognition, obsessive-compulsive symptoms, psychosocial functioning, quality of… |
| Interventions | Trade Name: Ebixa Product Name: Memantine hydrochloride Product Code: EU/1/02/219/023 Pharmaceutical Form: Film-coated tablet INN or Proposed INN: Memantine hydrochloride CAS Number: S 10102-43-9 Current Sponsor code: Unknown Other… |
| Registration date | Jan 29, 2013 |
| Secondary IDs | 1103-011 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: